Currently Viewing:
Patient-Centered Oncology Care
Currently Reading
Oncologists Can Save Oncology If They Take Ownership of Costs, Kolodziej Says
November 17, 2017
Documenting When a Patient Falls Outside a Recommended Pathway
November 20, 2017
Ian Manners: Addressing Financial Toxicity for Patients
November 29, 2017
The Importance of Teamwork in Oncology Care Transitions
November 30, 2017
Dr Brenton Fargnoli Highlights How Practices Can Prepare for Downside Risk
December 15, 2017
Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays
December 24, 2017
Torrie Fields: Data Collection Takes the Guesswork Out of Care
January 01, 2018
Kathleen Lokay on How Data Generation Informs Clinical Pathways
January 16, 2018
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
January 25, 2018
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
February 09, 2018
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Dr Stacey McCullough on the Pharmacist's Role in Patient Education
March 29, 2018
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13, 2018

Ian Manners Explains How Vivor Empowers Providers and Financial Navigators

Vivor helps patients receive financial assistance by focusing on empowering the providers and making it easier for financial navigators to do their job, said Ian Manners, founder and CEO of Vivor.


Vivor helps patients receive financial assistance by focusing on empowering the providers and making it easier for financial navigators to do their job, said Ian Manners, founder and CEO of Vivor.

Transcript

How is VIvor helping patients receive financial assistance?

We really focus on empowering providers. So, we find that our tools are most effective when they’re paired up with a great financial navigator or financial advocate who works right there in the private practice or in the hospital. That’s someone who can meet with the patient in person, really make sure that they’re intervening early on in a treatment process or even before treatment is begun.

We really make it easier for the financial advocate or navigator to do his or her job better. We give them the tools so they know exactly what kinds of answers to provide for their patient. We give them print outs that they can share with patients with information about financial resources, pin codes that the patient can then go enter on a mobile device or a laptop at home once they’ve had a chance to digest everything and talk it over with family members and caregivers.

Really, it’s all about empowering that person who is at the bedside, to do a better job of working with the patient.

What are the most common disease states you see among patients Vivor is working with?

We cover the gamut. We cover all specialty drugs, all disease areas that are made available through nonprofit foundations nationally. We track around 700 different sources of assistance. But oncology happens to be where the need is most focused, most acute. Around half of the resources that we track are in oncology, and I would say that the majority of the programs that we’re working with on the provider side are cancer centers.

That said, they tend to work with a large range of patient populations, just because when they’re operating in an infusion center, most likely they’re going to be treating patients with rheumatoid arthritis, with multiple sclerosis, many other indications where there are infused medicines.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!